150 related articles for article (PubMed ID: 11127819)
41. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
Crook T; Tidy JA; Vousden KH
Cell; 1991 Nov; 67(3):547-56. PubMed ID: 1657399
[TBL] [Abstract][Full Text] [Related]
42. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
[TBL] [Abstract][Full Text] [Related]
43. Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent.
Grm HS; Banks L
J Gen Virol; 2004 Oct; 85(Pt 10):2815-2819. PubMed ID: 15448342
[TBL] [Abstract][Full Text] [Related]
44. Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18.
Stewart D; Kazemi S; Li S; Massimi P; Banks L; Koromilas AE; Matlashewski G
J Gen Virol; 2004 Jun; 85(Pt 6):1419-1426. PubMed ID: 15166424
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome.
Favre-Bonvin A; Reynaud C; Kretz-Remy C; Jalinot P
J Virol; 2005 Apr; 79(7):4229-37. PubMed ID: 15767424
[TBL] [Abstract][Full Text] [Related]
46. Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain.
Araujo-Arcos LE; Montaño S; Bello-Rios C; Garibay-Cerdenares OL; Leyva-Vázquez MA; Illades-Aguiar B
Sci Rep; 2022 Feb; 12(1):1898. PubMed ID: 35115618
[TBL] [Abstract][Full Text] [Related]
47. A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein.
Dymalla S; Scheffner M; Weber E; Sehr P; Lohrey C; Hoppe-Seyler F; Hoppe-Seyler K
J Mol Med (Berl); 2009 Mar; 87(3):321-31. PubMed ID: 19099279
[TBL] [Abstract][Full Text] [Related]
48. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6.
Crook T; Ludwig RL; Marston NJ; Willkomm D; Vousden KH
Virology; 1996 Mar; 217(1):285-92. PubMed ID: 8599213
[TBL] [Abstract][Full Text] [Related]
49. Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein.
Facciuto F; Bugnon Valdano M; Marziali F; Massimi P; Banks L; Cavatorta AL; Gardiol D
Mol Oncol; 2014 May; 8(3):533-43. PubMed ID: 24462519
[TBL] [Abstract][Full Text] [Related]
50. Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium.
Nguyen MM; Nguyen ML; Caruana G; Bernstein A; Lambert PF; Griep AE
Mol Cell Biol; 2003 Dec; 23(24):8970-81. PubMed ID: 14645510
[TBL] [Abstract][Full Text] [Related]
51. Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli.
Takizawa S; Nagasaka K; Nakagawa S; Yano T; Nakagawa K; Yasugi T; Takeuchi T; Kanda T; Huibregtse JM; Akiyama T; Taketani Y
Genes Cells; 2006 Apr; 11(4):453-64. PubMed ID: 16611247
[TBL] [Abstract][Full Text] [Related]
52. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins.
Thomas M; Massimi P; Navarro C; Borg JP; Banks L
Oncogene; 2005 Sep; 24(41):6222-30. PubMed ID: 16103886
[TBL] [Abstract][Full Text] [Related]
53. The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins.
Kuballa P; Matentzoglu K; Scheffner M
J Biol Chem; 2007 Jan; 282(1):65-71. PubMed ID: 17085449
[TBL] [Abstract][Full Text] [Related]
54. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins.
Lee SS; Glaunsinger B; Mantovani F; Banks L; Javier RT
J Virol; 2000 Oct; 74(20):9680-93. PubMed ID: 11000240
[TBL] [Abstract][Full Text] [Related]
55. Degradation of Human PDZ-Proteins by Human Alphapapillomaviruses Represents an Evolutionary Adaptation to a Novel Cellular Niche.
Van Doorslaer K; DeSalle R; Einstein MH; Burk RD
PLoS Pathog; 2015 Jun; 11(6):e1004980. PubMed ID: 26086730
[TBL] [Abstract][Full Text] [Related]
56. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
[TBL] [Abstract][Full Text] [Related]
57. Binding of PDZ proteins to HPV E6 proteins does neither correlate with epidemiological risk classification nor with the immortalization of foreskin keratinocytes.
Muench P; Hiller T; Probst S; Florea AM; Stubenrauch F; Iftner T
Virology; 2009 May; 387(2):380-7. PubMed ID: 19285702
[TBL] [Abstract][Full Text] [Related]
58. Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97.
Chi CN; Bach A; Engström Å; Strømgaard K; Lundström P; Ferguson N; Jemth P
J Biol Chem; 2011 Feb; 286(5):3597-606. PubMed ID: 21113079
[TBL] [Abstract][Full Text] [Related]
59. A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor.
Padash Barmchi M; Gilbert M; Thomas M; Banks L; Zhang B; Auld VJ
PLoS Pathog; 2016 Aug; 12(8):e1005789. PubMed ID: 27537218
[TBL] [Abstract][Full Text] [Related]
60. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.
Zanier K; Charbonnier S; Baltzinger M; Nominé Y; Altschuh D; Travé G
J Mol Biol; 2005 Jun; 349(2):401-12. PubMed ID: 15890204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
